The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
Open accessAbstract
The cystic fibrosis transmembrane conductance regulator (CFTR) acts as a channel on the apical membrane of epithelia. Disease-causing mutations in the cystic fibrosis gene can lead to CFTR protein misfolding as in the case of the F508del mutation and/or channel dysfunction. Recently, a small molecule, VX-770 (ivacaftor), has shown efficacy in restoring lung function in patients bearing the G551D mutation, and this has been linked to repair of its channel gating defect. However, these studies did not reveal the mechanism of action of VX-770 in detail. Normally, CFTR channel activity is regulated by phosphorylation, ATP binding, and hydrolysis. Hence, it has been hypothesized that VX-770 modifies one or more of these metabolic events. In this study, we examined VX-770 activity using a reconstitution system for purified CFTR protein, a system that enables control of known regulatory factors. We studied the consequences of VX-770 interaction with CFTR incorporated in planar lipid bilayers and in proteoliposomes, using a novel flux-based assay. We found that purified and phosphorylated CFTR was potentiated in the presence of Mg-ATP, suggesting that VX-770 bound directly to the CFTR protein, rather than associated kinases or phosphatases. Interestingly, we also found that VX-770 enhanced the channel activity of purified and mutant CFTR in the nominal absence of Mg-ATP. These findings suggest that VX-770 can cause CFTR channel opening through a nonconventional ATP-independent mechanism. This work sets the stage for future studies of the structural properties that mediate CFTR gating using VX-770 as a probe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,228
Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity
Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., & Welsh, M. J. (1991) · Science · doi:10.1126/science.1712984 · Cited by 1,137
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Bear, C. E., Li, C., Kartner, N., Bridges, R. J., Jensen, T. J., Ramjeesingh, M., & Riordan, J. R. (1992) · Cell · doi:10.1016/0092-8674(92)90155-6 · Cited by 945
Self-citationEffect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 807
Phosphorylation-regulated CI− channel in CHO cells stably expressing the cystic fibrosis gene
Tabcharani, J. A., Chang, X.-B., Riordan, J. R., & Hanrahan, J. W. (1991) · Nature · doi:10.1038/352628a0 · Cited by 560
Generation of cAMP-Activated Chloride Currents by Expression of CFTR
Anderson, M. P., Rich, D. P., Gregory, R. J., Smith, A. E., & Welsh, M. J. (1991) · Science · doi:10.1126/science.1704151 · Cited by 550
Nucleoside triphosphates are required to open the CFTR chloride channel
Anderson, M. P., Berger, H. A., Rich, D. P., Gregory, R. J., Smith, A. E., & Welsh, M. J. (1991) · Cell · doi:10.1016/0092-8674(91)90072-7 · Cited by 527
Van Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 512
Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In Xenopus Oocytes
Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., Dawson, D. C., & Collins, F. S. (1991) · Science · doi:10.1126/science.1722350 · Cited by 496
Kartner, N., Hanrahan, J. W., Jensen, T. J., Naismith, A. L., Sun, S., Ackerley, C. A., Reyes, E. F., Tsui, L.-C., Rommens, J. M., Bear, C. E., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90498-n · Cited by 496
Self-citationCFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains
Vergani, P., Lockless, S. W., Nairn, A. C., & Gadsby, D. C. (2005) · Nature · doi:10.1038/nature03313 · Cited by 416
Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
Okiyoneda, T., Barrière, H., Bagdány, M., Rabeh, W. M., Du, K., Höhfeld, J., Young, J. C., & Lukacs, G. L. (2010) · Science · doi:10.1126/science.1191542 · Cited by 408
Chang, X. B., Tabcharani, J. A., Hou, Y. X., Jensen, T. J., Kartner, N., Alon, N., Hanrahan, J. W., & Riordan, J. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82125-1 · Cited by 296
ATPase Activity of the Cystic Fibrosis Transmembrane Conductance Regulator
Li, C., Ramjeesingh, M., Wang, W., Garami, E., Hewryk, M., Lee, D., Rommens, J. M., Galley, K., & Bear, C. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28463 · Cited by 267
Self-citationCoupling of CFTR Cl− channel gating to an ATP hydrolysis cycle
Baukrowitz, T., Hwang, T.-C., Nairn, A. C., & Gadsby, D. C. (1994) · Neuron · doi:10.1016/0896-6273(94)90206-2 · Cited by 212
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene.
Bear, C. E., Duguay, F., Naismith, A. L., Kartner, N., Hanrahan, J. W., & Riordan, J. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54971-1 · Cited by 191
Self-citationThe cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR
Li, C., Ramjeesingh, M., Reyes, E., Jensen, T., Chang, X., Rommens, J. M., & Bear, C. E. (1993) · Nature Genetics · doi:10.1038/ng0493-311 · Cited by 191
Self-citationGating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation
Hwang, T., & Sheppard, D. N. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.171595 · Cited by 170
Bompadre, S. G., Sohma, Y., Li, M., & Hwang, T. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200609667 · Cited by 159
Uncoupling and Turnover in a Cl−/H+ Exchange Transporter
Walden, M., Accardi, A., Wu, F., Xu, C., Williams, C., & Miller, C. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200709756 · Cited by 142
Roxo‐Rosa, M., Xu, Z., Schmidt, A., Neto, M. F., Cai, Z., Soares, C. M., Sheppard, D. N., & Amaral, M. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608312103 · Cited by 121
Amphiphile regulation of ion channel function by changes in the bilayer spring constant
Lundbæk, J. A., Koeppe, R. E., & Andersen, O. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007455107 · Cited by 116
Functional Reconstitution of Purified Human Hv1 H+ Channels
Lee, S., Letts, J. A., & MacKinnon, R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.034 · Cited by 112
Ramjeesingh, M., Li, C., Garami, E., Huan, L., Galley, K. A., Wang, Y., & Bear, C. E. (1999) · Biochemistry · doi:10.1021/bi982243y · Cited by 110
Self-citationCai, Z., Taddei, A., & Sheppard, D. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510576200 · Cited by 98
Wang, W., Bernard, K. F., Li, G., & Kirk, K. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609942200 · Cited by 93
What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect
Proesmans, M., Vermeulen, F. L., & Boeck, K. D. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0693-2 · Cited by 92
ATP-independent CFTR channel gating and allosteric modulation by phosphorylation
Wang, W., Wu, J., Bernard, K. F., Li, G., Wang, G., Bevensee, M. O., & Kirk, K. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913001107 · Cited by 85
Wellhauser, L., Chiaw, P. K., Pasyk, S., Li, C., Ramjeesingh, M., & Bear, C. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055608 · Cited by 83
Self-citationA Chemical Corrector Modifies the Channel Function of F508del-CFTR
Chiaw, P. K., Wellhauser, L., Huan, L., Ramjeesingh, M., & Bear, C. E. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065862 · Cited by 70
Self-citationJih, K., Li, M., Hwang, T., & Bompadre, S. G. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.202861 · Cited by 59
4 Regulation of CFTR Cl− ion channels by phosphorylation and dephosphorylation
Gadsby, D. C., & Nairn, A. C. (1999) · Advances in second messenger and phosphoprotein research · doi:10.1016/s1040-7952(99)80006-8 · Cited by 54
Kirk, K. L., & Wang, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.219634 · Cited by 44
Bernard, K. F., Wang, W., Narlawar, R., Schmidt, B., & Kirk, K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056010 · Cited by 38
The intact CFTR protein mediates ATPase rather than adenylate kinase activity
Ramjeesingh, M., Ugwu, F., Stratford, F. L. L., Huan, L., Li, C., & Bear, C. E. (2008) · Biochemical Journal · doi:10.1042/bj20071719 · Cited by 31
Self-citationArtigas, P., Alaref, S. J., Hobart, E. A., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026070 · Cited by 28
Studies of the Molecular Basis for Cystic Fibrosis Using Purified Reconstituted CFTR Protein
Kogan, I., Ramjeesingh, M., Li, C., & Bear, C. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-187-6:143 · Cited by 16
Self-citation
Cited by
The future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Cystic fibrosis genetics: from molecular understanding to clinical application
Cutting, G. R. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3849 · Cited by 965
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Okiyoneda, T., Veit, G., Dekkers, J. F., Bagdany, M., Soya, N., Xu, H., Roldan, A., Verkman, A. S., Kurth, M., Simon, A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1253 · Cited by 378
Gribkoff, V. K., & Kaczmarek, L. K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.021 · Cited by 371
Metadata
- Authors
- Eckford, P. D. W., Li, C., Ramjeesingh, M., & Bear, C. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 287
- Issue
- 44
- Pages
- 36639-36649
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1991977085
- Cited by
- 309
- References
- 41
- FWCI
- 22.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.